Related Experiment Video

Updated: Aug 9, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

The major subtypes of human B-cell lymphomas lack mutations in BCL-2 family member BAD

Roland Schmitz1, Roman K Thomas, Anne C Harttrampf

  • 1Institute for Cell Biology (Tumor Research), University of Duisburg-Essen, Medical School, Essen, Germany. roland.schmitz@uni-essen.de

International Journal of Cancer
|April 29, 2006
PubMed

Insights

Mutations in the BAD gene are not implicated in human B-cell lymphomas. This study found no inactivating mutations in the BAD gene across major human B-cell lymphoma subtypes, suggesting it does not contribute to their development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The BCL-2 gene family plays a crucial role in the development of B-cell lymphomas.
  • Previous research indicated that mice lacking the proapoptotic gene BAD developed B-cell lymphomas.

Purpose of the Study:

  • To investigate the potential role of inactivating mutations in the BAD gene in the pathogenesis of human B-cell lymphomas.

Main Methods:

  • Analysis of 81 human B-cell lymphoma samples, including various subtypes like chronic lymphocytic leukemia, mantle-cell lymphoma, follicular lymphoma, MALT lymphoma, Burkitt's lymphoma, multiple myeloma, diffuse large B-cell lymphoma, and Hodgkin's lymphoma.
  • Amplification and direct sequencing of all three exons of the BAD gene.

Main Results:

  • No inactivating mutations in the BAD gene were detected in any of the analyzed human B-cell lymphoma cases.
  • This finding contrasts with observations in knockout mouse models deficient for BAD.

Conclusions:

  • Mutations in the BAD gene are not a significant factor in the pathogenesis of major human B-cell lymphoma subtypes.
  • The role of BAD in lymphomagenesis may differ between mouse models and human disease.

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...